# OnCo record cfi-400945 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cfi-400945/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cfi-400945" ;
  schema:name "CFI-400945"@en ;
  schema:description "CFI-400945 is an experimental small molecule from Treadwell Therapeutics, in phase 2 trials for acute myeloid leukaemia, myelodysplastic syndromes and chronic myelomonocytic leukaemia and other cancers."@en ;
  schema:url <https://onco.cc/drugs/cfi-400945/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://treadwelltx.com/pipeline/>, <https://treadwelltx.com/pipeline/>, <https://clinicaltrials.gov/search?intr=CFI-400945> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds/>, <https://onco.cc/cancers/cmml/>, <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/plk4/> ;
  onco:companies <https://onco.cc/companies/treadwell-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct04730258/>, <https://onco.cc/trials/nct03187288/>, <https://onco.cc/trials/nct01954316/>, <https://onco.cc/trials/nct03624543/>, <https://onco.cc/trials/nct04176848/>, <https://onco.cc/trials/nct03385655/>, <https://onco.cc/trials/nct05601440/> .